Tag Archives: intellectual property

Abbvie V. Janssen Biotech –Written Description Requirement Road Map

The recent decision in Abbvie Deutschland v. Janssen Biotech and Centorcor Biologics, App. No. 2013-1338, -1346 (Fed. Cir. , July 1, 2014) deserves more attention than it has received. (A copy of the decision is available at the end of … Continue reading

Posted in Written Description Requirements (WDR) | Tagged , , , , , , , , , | 1 Comment

More Questions Than Answers from the PTO

At the recent BIO International Convention, Deputy Commissioner Andrew Hirschfeld (who chaired the May PTO s.101 Forum) presented seven “Sample Claims” related to biotech/pharma inventions and invited “discussion and feedback” from the interested public. The claims have been posted on … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , | 1 Comment

URGENT – COMMENTS DEADLINE EXTENDED

The deadline for Myriad-Mayo comments has been extended by a month. Info on the USPTO website and can be found here.  

Posted in USPTO Practice and Policy | Tagged , , , , , , , , | Leave a comment

USPTO issues post- Alice examination guidelines

A copy of the guidelines can be found here: alice_pec_25jun2014 I will comment on this later.  

Posted in Patent Eligible Subject Matter | Tagged , , , , , , | Leave a comment